Uncategorized Archives - MPM Capital

10th October 2023

AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer’s disease

28th September 2023

Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact

21st September 2023

The Endpoints 11: The biotech startups making the biggest bets with the most exciting science in 2023

19th September 2023

ReCode Therapeutics Announces Closing of Extension to Series B Financing